RLYP I am surprised that BofA didn't ramp up their estimate of first year sales at $23 million after reading their survey. They did say that their estimate is "conservative" based on the survey. I added shares this morning.
Wade: RLYP price target of $27 sounds reasonable .... I don't think your short term $40 price target is realistic. Merrill sales forecast for 2016 is very disappointing, so let's hope they're wrong. I'm trading and hedging around a core position for now.
I have no interest in owning KERX at $5, but good luck with it. I think they'll need another cash infusion in a year from now just to stay afloat unless their drug sales suddenly zoom which I doubt.
News 
Market Data 
Discover 
AI
